Medical Care Technologies, Inc. Begins Development of Image Capture for Autism Using Tele-Health(TM) Suite

BEIJING--(Marketwire - February 04, 2010) - Medical Care Technologies Inc. (OTCBB: MDCE) today announced the initial development of Tele-Health™ Suite 6.17 technology with image capture for Autism. This technology will allow families and professionals to record behaviours and catalogue them within our Medsuite™ for further analysis and treatment. Diagnosis relies on behavioural observation and screening.

One of the most important child health issues gaining international attention is the cluster of conditions known as Autism Spectrum Disorder or ASD. It is also sometimes referred to as Pervasive Developmental Disorder or PDD. The most available information on autism focuses on children with the condition, even though ASD persists when they become adults.

In 2007, the World Health Organization (WHO) argued that the world faces a critical problem with the growing number of people with mental and neurological problems, including autism, which accounts for 11% of global disease. The number is projected to reach 14.7% by 2020. Specifically for China, the WHO reported 1,100,000 cases of autism. George Hackworth's article, Autism and Global Human Rights, reports that "the rate of autism is growing at 14% around the world, but in China it's growing at a rate of 20% per year."

Ning Wu, President of Medical Care Technologies states, "The importance of the Medical Care Technologies image capture technology is to assist in early detection of symptoms. Early symptom recognition and intervention can help the child function at his or her highest possible level and it is our belief that early detection of autistic symptomtology is key to better treatment outcomes for autism in China."

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (www.medicaretech.com) is traded under the symbol MDCE on the OTCBB and is based in London, England. The Company is in the process of moving its portfolio of oil resources into medical care technologies. The products/services that the company hopes to acquire are intended to constitute a healthcare delivery and wellness site, dedicated to helping Asian consumers live healthier, more balanced lives. MDCE is planning to provide advanced connectivity, internationally standardized and secure business technology and information systems to assist the Asian health industry -- physicians, pharmacists, medical institutions, and consumers -- in accessing medical resources, health services, education, wellness and pharmaceutical products throughout Asia. MDCE is planning to distribute and provide services at a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Nutraceuticals. Further information on the Company can be found at www.sec.gov and the company's website at www.medicaretech.com

Safe Harbor Statement

All statements contained in this press release, other than statements of historical fact, are forward-looking statements, including those regarding: MDCE's products, services, capabilities, performance, opportunities, development and business outlook, guidance on our future financial results and other projections or measures of our future performance; the amount and timing of the benefits expected from strategic initiatives and acquisitions or from deployment of new or updated technologies, products, services or applications; and other potential sources of additional revenue. These statements are based on our current plans and expectations and involve risks and uncertainties that could cause actual future events or results to be different than those described in or implied by such forward-looking statements. These risks and uncertainties include those relating to: lack of operating history, transitioning from a development company to an operating company, difficulties in distinguishing MDCE's products and services, ability to deploy MDCE's services and products, market acceptance of our products and services; operational difficulties relating to combining acquired companies and businesses; our ability to form and maintain mutually beneficial relationships with customers and strategic partners; changes in economic, political or regulatory conditions or other trends affecting the healthcare, Internet, information technology and healthcare and pharmaceutical industries, and our ability to attract and retain qualified personnel. Other risks and uncertainties may include, but are not limited to: lack of or delay in market acceptance and fluctuations in customer demand, dependence on a limited number of significant customers, reliance on third party vendors and strategic partners, ability to meet future capital requirements on acceptable terms, continuing uncertainty in the global economy, and compliance with federal and state regulatory requirement. Further information about these matters can be found in our Securities and Exchange Commission filings. We expressly disclaim any intent or obligation to update these forward-looking statements. There can be no assurance that the acquisition of GUC's assets will close. MDCE must issue 57,300,000 shares of its common stock to GUC, or GUC's designees in order to close the acquisition. Accounting for the anticipated cancellation of 57,300,000 shares by Patricia Traczykowski, MDCE will have 98,900,000 shares of its common stock issued and outstanding upon the closing of the acquisition.